THE title Morbus Maculosis Werlhofii for the severe form of purpura haemorrhagica is derived from the fact that the first clear and accurate clinical account of this condition was made by Werlhof in 1775. However, over two centuries earlier, a Portuguese called Amatus Lusitanus described in one of his works, under the title of Morbus Pulicaris Absque Febre, the case of a boy with undoubted acute haemorrhagic purpura who had a spontaneous recovery. Indeed, little can be added to-day to these earlier clinical descriptions which are full of the fruits of keen observation and reflect the scholarship of their age.
The disease is characterised by the presence of petechial hoemorrhages in the skin-compared by one earlier worker to "flea bitings." These are more commonly seen in the limbs but may also occur on the trunk. These minute haemorrhages may spread to produce purpuric spots or coalesce to form extensive superficial ecchymoses. Associated lesions are commonly seen in the buccal mucosa where they assume the characters of blood filled blisters. These manifestations are associated with free bleeding from mucous surfaces with epistaxis, hoematuria, haematemesis or persistent oozing from the gums. In women profuse uterine bleeding is not uncommon and may be the presenting sign and reason for the patient's hospitalisation, as it has been in two of our cases.
It was not until late in the nineteenth century that Bizzozero (1882) noted the relationship of blood platelets to clot formation and this was quickly followed by the observation in some cases of purpura of a diminished number of circulating blood platelets. Thus, the understanding of the function of blood platelets preceded any knowledge as to their origin, which was the subject of considerable dispute until Wright (1910) clearly demonstrated platelets budding off from the megakaryocytes of the bone marrow.
Further study of the relationship of circulating blood platelets to the presence of clinical purpura received intensive study which revealed that there were two major kinds of purpura. In the first of these the number of circulating blood platelets is normal. This is called non-thrombocytopenic purpura and in this type the bleeding is almost certainly due to a disturbance of the walls of blood vessels. In the second type the number of circulating blood platelets is reduced. This is called thrombocytopenic purpura and in this type the bleeding is clearly related to the diminished number of circulating blood platelets although, an associated vascular defect cannot be entirely excluded.
Purpura with a decrease in the circulating blood platelets can be produced in a number of ways. It is often secondary to other diseases, particularly those diseases of the haemopoietic system, which are associated with marrow replacement and consequent reduction in the number or interference with the function of the parent megakaryocytes. Thrombocytopenic purpura may also be caused by the damaging effect of hamatotoxic drugs on the megakaryocytes of the bone marrow. Because of the oetiology, this type is known as 'secondary thrombocytopenic purpura.' In other cases, however, no known cause for the thrombocytopenia can be discovered and these are classified as 'primary' or 'idiopathic thrombocytopenic purpura.' IDIOPATHIC THROMBOCYTOPENIC PURPURA.
The mechanism for the production of thrombocytopenia in this type of purpura has been the subject of controversy. The theories can be broadly classified into those which envisage increased peripheral destruction or utilisation of platelets and those which regard the reduced platelet count in the peripheral blood as being the result of diminished platelet formation in the bone marrow. Kaznelson (1916) postulated an accelerated phagocytosis of platelets by the spleen and introduced splenectomy for treatment. This theory of excessive destruction of platelets in the reticulo-endothelial system is supported by Wiseman, Doan and Wilson (1940) . An alternative method of producing a diminution of circulating blood platelets by peripheral utilisation was suggested by Tidy (1926) . He considered that the primary defect lay in the capillary endothelium and that excessive numbers of platelets were used in plugging vascular breaches.
The opposing theory of diminished platelet formation has many adherents since Frank (1925) first suggested that the peripheral thrombocytopenia was due to reduced platelet formation from megakaryocytes under the influence of the spleen. This led Troland and Lee (1938) and many others to attempt to produce thrombocytopenia in experimental animals, using splenic extracts. These experiments produced very variable results. Indirect support for this theory of Frank was adduced by Dameshek and Miller (1946) , who demonstrated the presence of a marked hyperplasia and maturation arrest of the megakaryocytes in the bone marrow of untreated cases of chronic purpura. The restoration of the megakaryocytic pattern to normal following splenectomy led these authors to postulate the presence of a splenic inhibitory substance which caused arrest of megakaryocytic maturation.
The theory of peripheral platelet destruction has once again come into prominence following the work of Evans et al. (1951) , who put forward evidence of an auto-immune mechanism in thrombocytopenic purpura similar to that responsible for the erythrocytic destruction in acquired haemolytic anaemia. This has been supported by Harrington and his co-workers (1951) , who have demonstrated an anti-platelet immune body in the serum of some patients with thrombocytopenic purpura. Such a serum is capable of producing thrombocytopenia and clinical purpura when injected intravenously into normal individuals.
From the diagnostic point of view idiopathic thrombocytopenic purpura is regarded as that group of diseases characterised by a hemorrhagic diathesis which manifests itself as ready bruising or free bleeding from mucous surfaces. Haemorrhages may also occur into the skin producing petechiae, purpuric spots or ecchymoses. The bleeding time is prolonged, the capillaries are unduly fragile and, although the clotting time is normal, the clot fails to retract normally. The platelet count is usually less than 100,000 per c.mm. but no evident cause for the thrombocytopenia can be found. There may be slight anaemia but severe anaemia is uncommon, and whatever its degree .it is always explicable by the severity of the blood loss. Enlargement of the spleen is so uncommon in primary thrombocytopenic purpura that it can be used as a clinical differential diagnostic sign from purpura secondary to diseases of the reticulo-endothelial system. Acute Idiopathic Thrombocytopenic Purpura.
Although all cases of idiopathic thrombocytopenic purpura satisfy the above general diagnostic criteria, two distinct clinical varieties of this disease occur (Hirsch and Dameshek, 1951) . These differ in onset, clinical course, treatment and prognosis. The first of these is acute thrombocytopenic purpura which is well illustrated by the following case:-Case 1.-A 41-year-old woman with no family history of bleeding had never suffered from any tendency to haemorrhage during her lifetime and had not taken any drugs. One day she slipped and fell, bruising her left leg. This bruise spread to produce an extensive ecchymosis. Within four hours both her legs became covered with numerous small blue spots and further large spontaneous bruises appeared. Severe epistaxis and vaginal hamorrhage then developed and she was immediately admitted to hospital.
On examination there was generalised and extensive purpura of the skin of all four limbs, chest, and abdomen. This was most marked around the ankles and was associated with several large ecchymoses. Purpuric spots and blood-filled blisters were present on the buccal mucosa. Bleeding occurred from the nose and the vagina and catheter specimen of urine contained visible macroscopic blood.
The haemoglobin was 74% Haldane=10.9 gms./100 ml.; erythrocytes 3.74 x 106 per c.mm., leucocytes 3,100 per c.mm.; platelets 90,000 per c.mm.; bleeding time grossly prolonged; clotting time normal; clot retraction poor. While in hospital the epistaxis continued despite local hamostatic measures and further crops of purpuric spots appeared. Two days after admission, when the platelet count had fallen further to 52,000 per c.mm., the patient received one pint (570 mls.) of fresh compatible whole blood. The bleeding immediately ceased from all mucous surfaces and the purpuric rash subsided. Ten days after the onset the patient had recovered completely; the platelets had risen to 280,000 per c.mm.; the bleeding time was normal and the clot retraction good.
In this case the onset was sudden and dramatic in a patient with no previous history of bleeding or ready bruising. Following an injury the patient noticed a shower of purpuric spots on the legs which spread to involve the trunk and upper limbs. These purpuric spots coalesced to form large ecchymoses. Bleeding occurred from mucous surfaces with gross epistaxis and menorrhagia. Examination of the blood showed a low platelet count which fell at one time to 52,000 per c.mm., and 115 a poorly retractile blood clot. The bleeding time was grossly prolonged. The clinical manifestation lasted only a few days and the platelet count returned to normal in ten days, the patient making a complete recovery. As acute thrombocytopenic purpura is a self.limited disease with spontaneous and permanent recovery usually within 4 weeks, treatment consists largely of expectancy. In purpura there is always a danger of cerebral haemorrhage in patients over 40 years of age and consequently it may be necessary to control the haemorrhagic episodes by transfusions of fresh (not stored) whole blood. Splenectomy, which always carries an added risk if performed during an acute hawmorrhagic phase, is not usually indicated.
Chronic Idiopathic Thrombocytopenic Purpura.
In chronic thrombocytopenic purpura the onset is gradual and the patient usually gives a history of bleeding or ready bruising for many years with periods of exacerbation and remission. Scattered petechie may appear from time to time but true purpura may be entirely lacking. For this reason Hirsch and Dameshek (1951) have suggested that the term purpura should be omitted from the descriptive title of the disease which they suggest should be known as the "chronic" thrombocytopenic state.
In this type of purpura the platelet count is only significantly reduced at periods of relapse and in periods of remission may be normal. This also applies to the other tests used in the diagnosis. On examination of the bone marrow the presence of a megakaryocytic hyperplasia with no evidence of platelet production is the usual but not invariable finding and it was this which led Dameshek and Miller (1946) to postulate an inhibitory effect on the marrow by the spleen in this disease.
Although splenectomy is usually immediately curative of the bleeding tendency, as the normal course of the disease is subject to spontaneous fluctuations, the treatment can only be regarded as successful if no further bleeding has occurred for a period of six months after operation and if the platelet count remains normal for the same period.
The following is an example of a case of chronic thrombocytopenia successfully treated by splenectomy :
Case 2.-A 22-year-old chemist's assistant had always had severe and prolonged menstrual bleeding since her menarche at 14, although her cycle was regular. She had noticed a tendency to undue haemorrhage from tooth extractions and superficial wounds but had not noticed spontaneous haemorrhage or 'spots' on the skin. There was no family history of bleeding and the patient had not been exposed to any toxic drug.
When seen at the outpatient department her haemoglobin was 75% Haldane=11.1 gm./100 ml.; platelets 110,000 per c.mm.; bleeding time 6 mins.; coagulation time normal; prothrombin 100%. One month later she was admitted to hospital for investigation of her menorrhagia and when in hospital she suddenly developed showers of petechia~on her chest and limbs and bleeding from the gums. The spleen was not enlarged. As the condition of the patient was critical it was decided to remove the spleen. Accordingly pre-operative transfusion of fresh whole and stored blood was given to a total of 10 pints (5700 ml.) and a splenectomy successfully cariied out. Two days after the operation the platelet count began to rise and the bleeding time to return to normal and she made an uneventful recovery which has been maintained for the six months that the patient has remained under observation. In another case of chronic idiopathic thrombocytopenic purpura in a boy of 3 years, cortisone given in a dose of 100 mgm. daily for ten days produced considerable improvement in the bleeding time and platelet count but this effect was only temporary. A second remission was induced with cortisone and splenectomy successfully carried out.
Case 4.-A 3-year-old boy, with no family history of bleeding, first developed a generalised purpuric rash in March, 1952. There was no haemorrhage from the mucous membranes and no joint involvement. At that time the hWmoglobin was 88% Haldane= 13.0 gm./100 ml.; leucocytes 12,000 per c.mm.; platelets 355,000 per c.mm.; bleeding time 18 mins.; coagulation time normal. The purpura subsided but recurred within two months when it was accompanied by ecchymoses and epistaxis. The bleeding time was still prolonged although the platelet count was normal. The hlemorrhagic diathesis responded to the transfusion of one half pint (285 ml.) of fresh whole blood but this produced only temporary benefit. In July, 1952, because of a recurrence of ecchymosis and epistaxis, the patient was readmitted to hospital. The haemoglobin was 96% Haldane = 13.6 g. /100 ml.; leucocytes 11,900 per c.mm.; platelets 98,000 per c.mm.; bleeding time more than 15 mins. The bone marrow showed no increase in the number of megakaryocytes or evidence of morphological abnormalities. A course of cortisone consisting of 100 mgm. a day for ten days was then given and the dose gradually reduced over a further ten days. This produced considerable improvement in the clinical evidence of bleeding, caused a rise in the platelet count in the peripheral blood and restored the bleeding time to normal. This beneficial effect, however, only lasted 14 days when the platelet count fell to 50,000 per c.mm., the bleeding time again rose to more than 15 mins. and clinical purpura and ecchymoses reappeared. The boy was prepared for splenectomy by being given a short (5 day) course of cortisone consisting of 175 mgm. daily which again restored the bleeding time to normal. The post-operative course proceeded normally and no further episodes of haemorrhage have occurred. The platelet count and bleeding time have been restored to normal by the operation and have remained satisfactory for the six months that the child has been observed. SECONDARY THROMBOCYTOPENIC PURPURA. In secondary thrombocytopenic purpura a decrease in the circulating blood platelets may be produced as the result of the effect of haemototoxic drugs, and among such drugs are the organic arsenicals. The appearance of purpura during the therapy of syphilis with organic arsenicals may occur with dramatic suddenness and subside spontaneously once the drug is withdrawn, as the following case which was previously reported (Nelson, 1952) illustrates.
Case 5.-A 30-year-old woman with secondary sero-positive syphilis had been treated with 3 mega units of penicillin followed over a period of somewhat less than a year by 3 g. of bismuth metal, 0.86 g. of mapharsan and 7.2 g. of neoarsphenamine when she suddenly noted the development of a black spotted 'rash' on her body and bleeding from her gums. On admission to hospital an extensive petechial rash was present over the face, arms and legs, being most extensive on the limbs. She was bleeding from the gum margins and numerous blood-filled vesicles were seen in her mouth. This case illustrates the phenomenon of the reduction in the number of circulating blood platelets with the development of purpura and spontaneous mucosal haemorrhages as the result of exposure to a hwematotoxic drug. This toxic action affected only one cell system in the marrow, viz., the megakaryocytes.
Both the granulocytic and erythrocytic precursors were unaffected. There was no gross anwmia or leucopenia in the peripheral blood and, once exposure to the toxic drug ceased, a rapid rise in the platelet Count occurred with spontaneous recovery.
In patients with syphilis, who are treated by organic arsenicals and who develop thrombocytopenic purpura associated with peripheral pancytopenia, i.e., thrombocytopenia with severe anaemia and leukopenia, the marrow may be so damaged that recovery may not occur even with strenuous treatment with dimercaprol (Nelson, 1952) .
The appearance of spontaneous bleeding or skin purpura may herald the development of an aplastic or primary refractory anawmia. In certain cases the haemorrhagic diathesis may so dominate the picture as to raise the possibility of a diagnosis of primary idiopathic thrombocytopenic purpura. However, the presence of a persistent anmemia not explicable by blood loss and a granulocytopenia should arouse suspicion. The absence of primitive white cells in the peripheral blood and examination of the bone marrow will exclude the hoemorrhagic onset of a subleukaemic leuklemia. The bone marrow in chronic refractory anmmia may be cellular or even hyperplastic and is not necessarily aplastic. It is for this reason that the term 'primary refractory anaemia' is preferred for this group rather than aplastic anmemia where the peripheral pancytopenia is associated with a grossly acellular marrow.
Case 6.-A 22-year-old married woman had noticed, over a period of some ten months, that her menstrual loss had become increasingly heavy. She became weak and listless and was admitted to hospital, where she received a transfusion of eight pints (4560 ml.) of whole blood. The heavy menstrual loss continued and she developed frequent attacks of epistaxis which required her readmission to hospital. There was no enlargement of spleen or lymph nodes. Her hemoglobin was 41% Haldane= 6.1 g./100 ml.; erythrocytes 1.84 x 106 per c.mm.; P.C.V.=18%; M.C.V.=100 cu; leucocytes 2,530 per c.mm.; platelets 35,000 per c.mm.; bleeding time 20 mins.; 121 clotting time normal; prothrombin concentration 100%; capillary fragility increased. The marrow obtained by needle biopsy was examined on three occasions and showed a cellular marrow with a normoblastic erythropoiesis. Megakaryocytes were inconspicuous in the marrow but showed normal morphology. Because of the peripheral pancytopenia and cellular marrow a diagnosis of primary refractory anaemia was made. However, as the haemorrhagic diathesis continued despite fresh blood transfusions a splenectomy was carried out as a purely empirical measure in the hope of controlling the haemorrhage. Since this operation her menstrual loss has been less heavy and no further bleeding has occurred from other sites. However, her platelet count is still low, her bleeding time intermittently prolonged and her anaemia and leucopenia still present. DISCUSSION. Blood transfusion occupies pride of place in the treatment of purpura not only as a general supportive measure to combat shock and blood loss but also as an efficient haemostatic. As platelets disintegrate rapidly in contact with glass surfaces freshly drawn whole blood is preferable to banked blood. The more recent experiments carried out on blood withdrawn through silicone-coated tubing and stored in silicone-coated glassware have shown that this reduces greatly the rate of platelet distintegration. This technique offers the hope of transfusing a more platelet.rich blood in the future. Indeed the therapeutic value of this form of treatment in thrombocytopenia and thrombopathia has already been reported (van Creveld et al. 1953) , and in our hands has been most effective in controlling haemorrhage and raising the platelet count..
If the haemorrhage is due to a platelet deficiency produced by the effect of haematotoxic drugs acting on the megakaryocytes in the bone marrow, the outcome of drug withdrawal or elimination will largely depend on the degree and extent of damage to the immature cells in the marrow. When the megakaryocytes only are damaged, a pure thrombocytopenic purpura is produced without severe anaemia or leucopenia. Such cases have a prompt and spontaneous clinical and ha:matological recovery once the toxic drug is removed. When the marrow damage is extensive so that the megakaryocytes, the primitive granulocytes and the red cell precursors are all found to be affected, the hzemorrhagic diathesis is associated with severe anaemia and granulocytopenia and recovery is unlikely (Nelson, 1952) . The prognosis in cases of purpura due to hematotoxic drugs therefore depends on the damage to the whole haemopoietic system and the outcome can be inferred, to some extent, from an examination of the peripheral blood and bone marrow.
Purpura may complicate a number of diseases affecting the hawmopoietic system, where it is often a terminal manifestation. However, in some cases of refractory or aplastic an;emia the presence of purpura may be the presenting and predominating sign (Case 6). In the absence of any sure knowledge as to the atiology of primary refractory anamia and the lack of response to any of the known haemopoietic drugs these cases are usually maintained with blood transfusions. Although splenectomy has been carried out in some cases of primary refractory anaemia, the results have not been encouraging. It is only in cases with an active cellular marrow that splenectomy is likely to be followed by beneficial results. Here it is postulated that the spleen is exerting some inhibitory effect on the marrow which is relieved by splenectomy. In one case of primary refractory anemia presenting as a haemorrhagic diathesis the effect of removal of the spleen was to produce immediate cessation of the bleeding tendency with a temporary restoration of the bleeding time which has since shown frequent remissions and relapses. The low platelet, erythrocyte and leucocyte counts have persisted but the haemoglobin has, for a limited period, been fairly satisfactorily maintained so that the patient has only required a blood transfusion once in the twelve months since her operation. This case also clearly demonstrated the lack of correlation which can exist between the bleeding time and the platelet count. In purpura it has been shown that the bleeding time is paralleled by the capillary fragility but not by the platelet count, and that both bleeding time and capillary fragility are increased during periods of active bleeding with associated skin purpura. The only tests which can be correlated with any degree of accuracy with the platelet count are the clot retraction and rate of prothrombin consumption. This is one of the facts which suggests that the low platelet count is not entirely responsible for the haemorrhagic manifestations which may have an underlying vascular origin.
Acute idiopathic thrombocytopenic purpura has such a dramatic presentation and bleeding may be so profuse that the unwary may be trapped into carrying out an emergency splenectomy which carries an undue risk, if carried out under such circumstances. The management of these cases resolves itself into the control of the acute bleeding episode and the practice of a policy of watchful expectancy to see if spontaneous recovery occurs. Control of this bleeding can most readily be achieved by the transfusion of fresh (not stored) whole blood. The value of cortisone or A.C.T.H. in acute thrombocytopenic purpura is dubious, as some workers have been unable to detect any clinical or haematological difference in the course of patients treated with A.C.T.H. and cortisone and other patients left untreated. Because splenectomy is followed by clinical improvement in the bleeding tendency and a rise in the platelet count, the decision to carry out this operation in a case of acute thrombocytopenic purpura may be forced by the developments in the individual case which is not showing signs of spontaneous recovery. Under these circumstances the presence of uncontrollable hamorrhage threatening life or of severe bleeding, particularly in patients over 40 years of age where there is the ever-present risk of cerebral haemorrhage, are two possible indications for splenectomy.
Splenectomy in chronic thrombocytopenic purpura is the elective form of treatment and is followed by permanent recovery in a high percentage of cases. The decision here is the timing of the operation, for the risk is less if the operation is carried out once the acute hkemorrhagic episode has subsided. Here a preoperative course of cortisone or A.C.T.H. is most useful in helping to restore the bleeding time to normal and to control the haemorrhagic manifestations. This effect is maximal about the seventh day of administration and consequently the operation can be performed at a time when the risk of both operative and postoperative haemorrhage is reduced to a minimum.
The appropriate treatment of an individual case of idiopathic thrombocytopenic purpura may present a problem of considerable difficulty to the physician or surgeon. The major difficulty is to know whether the case is one of acute thrombocytopenic purpura or an acute episode in a chronic case. The most helpful points are (1) In chronic purpura there is a previous history of bleeding or ready bruising which is not obtained in acute purpura. (2) The clinical manifestations in acute purpura are those of severe bleeding with widespread gross purpura and ecchymoses, while in an acute exacerbation of chronic purpura the skin manifestations usually consist of petechiaw, localised to the legs rather than generalised purpura. (3) The haematological changes in acute purpura are more marked than in chronic purpura.
The differential diagnosis is important and not merely academic. It is the differential diagnosis between an acute self-limited disease in which the danger from splenectomy is great and a chronic persistent disorder in which, at the moment, splenectomy carries the only hope of complete cure. It is a problem which taxes to the full the judgement and skill of the physician.
SUMMARY.
Idiopathic thrombocytopenic purpura occurs in two clinical forms. Acute idiopathic thrombocytopenic purpura is a self-limited disease in which 12M control of severe haemorrhage can be achieved by the transfusion of fresh whole blood while awaiting spontaneous recovery.
Chronic idiopathic thrombocytopenic purpura is a disease liable to fluctuating remissions and relapses. In relapse the acute bleeding episode may be controlled by transfusion of fresh whole blood or cortisone therapy. If the bleeding is uncontrollable, threatening vital structures or is persistently recurrent, splenectomy is indicated.
In secondary thrombocytopenic purpura due to hematotoxic drugs, recovery is prompt following withdrawal of the drug. If the haematotoxic drug has produced severe marrow damage with peripheral pancytopenia the prognosis is poor.
In one case of primary refractory anzemia with a secondary thrombocytopenic purpura splenectomy has relieved the bleeding tendency without affecting significantly the underlying disease process.
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